Percheron Therapeutics Limited
PERCF
$0.0025
-$0.0165-86.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.76M | 12.06M | 7.92M | 7.74M | 11.72M |
| Total Receivables | 212.20K | 237.80K | 1.71M | 1.67M | 1.78M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 62.40K | 69.90K | 25.50K | 25.00K | 93.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 11.04M | 12.36M | 9.66M | 9.44M | 13.60M |
|
|
|||||
| Total Current Assets | 11.04M | 12.36M | 9.66M | 9.44M | 13.60M |
| Net Property, Plant & Equipment | 55.80K | 62.60K | 37.90K | 37.10K | 22.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 11.09M | 12.43M | 9.69M | 9.48M | 13.62M |
|
|
|||||
| Total Accounts Payable | 1.42M | 1.59M | 2.49M | 2.43M | 596.90K |
| Total Accrued Expenses | 164.20K | 183.90K | 923.10K | 902.20K | 1.79M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 44.80K | 50.20K | 26.60K | 26.00K | 11.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 100.00 |
| Total Other Current Liabilities | -- | -- | -- | -- | 100.00 |
| Total Current Liabilities | 1.63M | 1.82M | 3.44M | 3.36M | 2.40M |
|
|
|||||
| Total Current Liabilities | 1.63M | 1.82M | 3.44M | 3.36M | 2.40M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 10.10K | 9.90K | 4.10K |
| Total Liabilities | 1.63M | 1.82M | 3.45M | 3.37M | 2.41M |
|
|
|||||
| Common Stock & APIC | 76.37M | 85.56M | 72.97M | 71.32M | 74.55M |
| Retained Earnings | -68.24M | -76.45M | -67.87M | -66.34M | -64.45M |
| Treasury Stock & Other | 1.33M | 1.49M | 1.15M | 1.12M | 1.11M |
| Total Common Equity | 9.46M | 10.60M | 6.25M | 6.11M | 11.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.46M | 10.60M | 6.25M | 6.11M | 11.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9.46M | 10.60M | 6.25M | 6.11M | 11.21M |
|
|
|||||